NL8320427A - Proef op autoimmune rheumatoide arthritis. - Google Patents

Proef op autoimmune rheumatoide arthritis. Download PDF

Info

Publication number
NL8320427A
NL8320427A NL8320427A NL8320427A NL8320427A NL 8320427 A NL8320427 A NL 8320427A NL 8320427 A NL8320427 A NL 8320427A NL 8320427 A NL8320427 A NL 8320427A NL 8320427 A NL8320427 A NL 8320427A
Authority
NL
Netherlands
Prior art keywords
plasma
substrate
macroglobulin
buffered
hydrolyzable
Prior art date
Application number
NL8320427A
Other languages
English (en)
Dutch (nl)
Original Assignee
Teodorescu Marius C
Gaspap Alexander M
Spear Gregory Todd
Ganea Doina
Skosey John Lyle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teodorescu Marius C, Gaspap Alexander M, Spear Gregory Todd, Ganea Doina, Skosey John Lyle filed Critical Teodorescu Marius C
Publication of NL8320427A publication Critical patent/NL8320427A/nl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NL8320427A 1982-12-30 1983-12-29 Proef op autoimmune rheumatoide arthritis. NL8320427A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/454,788 US4499186A (en) 1982-12-30 1982-12-30 Diagnosing autoimmune rheumatoid arthritis by measuring proteolytic activity of α2 -macroglobulin
US45478882 1982-12-30
PCT/US1983/002051 WO1984002778A1 (en) 1982-12-30 1983-12-29 Test for autoimmune rheumatoid arthritis
US8302051 1983-12-29

Publications (1)

Publication Number Publication Date
NL8320427A true NL8320427A (nl) 1984-11-01

Family

ID=23806087

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8320427A NL8320427A (nl) 1982-12-30 1983-12-29 Proef op autoimmune rheumatoide arthritis.

Country Status (8)

Country Link
US (1) US4499186A (de)
EP (1) EP0131041A4 (de)
JP (1) JPS60501027A (de)
CH (1) CH666555A5 (de)
DE (1) DE3390431T1 (de)
GB (1) GB2142723B (de)
NL (1) NL8320427A (de)
WO (1) WO1984002778A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8304836D0 (sv) * 1983-09-09 1983-09-09 Pharmacia Ab Sett att bestemma forendringar i ledbrosk
US4645748A (en) * 1985-02-01 1987-02-24 Charles Hurwitz Protein which is characteristic of rheumatoid arthritis
DE3936256A1 (de) * 1989-10-31 1991-05-02 Max Planck Gesellschaft Test zur differentiellen quantifizierung des freien bzw. des peptidasekomplexierten proteinaseinhibitors (alpha)(pfeil abwaerts)2(pfeil abwaerts)-makroglobulin
US5075101A (en) * 1990-04-10 1991-12-24 Siguel Edward N Method for diagnosis of fatty acid or lipid abnormalities
WO1991019001A1 (en) * 1990-05-25 1991-12-12 British Technology Group Ltd Immunodiagnostic assay for rheumatoid arthritis
EP2531859A4 (de) * 2010-02-02 2013-07-31 Jolla Inst Allergy Immunolog Zusammensetzungen und verfahren zur modulierung von rezeptorprotein-tyrosin-phosphatasen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL60888A (en) * 1978-06-16 1984-07-31 Yeda Res & Dev Substrates and process for the quantitative assay of enzymes
US4221706A (en) * 1979-06-14 1980-09-09 Abbott Laboratories Chromogenic substrates
DE3172143D1 (en) * 1980-09-30 1985-10-10 Cornell Res Foundation Inc Process for determining inhibitor-enzyme complexes
US4402934A (en) * 1980-10-30 1983-09-06 Teodorescu Marius C Diagnostic technique for rheumatoid arthritis

Also Published As

Publication number Publication date
GB8421519D0 (en) 1984-09-26
JPS60501027A (ja) 1985-07-04
WO1984002778A1 (en) 1984-07-19
EP0131041A1 (de) 1985-01-16
EP0131041A4 (de) 1988-01-11
DE3390431T1 (de) 1985-05-15
GB2142723A (en) 1985-01-23
CH666555A5 (de) 1988-07-29
US4499186A (en) 1985-02-12
GB2142723B (en) 1986-10-22

Similar Documents

Publication Publication Date Title
REGAN et al. Platelet function and coagulation profile in lupus erythematosus: studies in 50 patients
Janes et al. Evaluation of whole blood flow cytometric detection of platelet bound fibrinogen on normal subjects and patients with activated platelets
Kurantsin‐Mills et al. Plasma factor VII and thrombin–antithrombin III levels indicate increased tissue factor activity in sickle cell patients
Helley et al. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and β-thalassemia
Akazawa et al. Hypercoagulable state in patients with Takayasu’s arteritis
Toulon et al. Heparin cofactor II deficiency in patients infected with the human immunodeficiency virus
Pearlman et al. The requirement of serine esterase function in complement-dependent erythrophagocytosis
Szymanski et al. Red blood cell associated IgG in normal and pathologic states
Pootrakul et al. Quantitation of ferritin iron in plasma, an explanation for non-transferrin iron
US5716795A (en) Thrombomodulin-based coagulometric assay of the protein C system
Diaz-Perez et al. The complement system in bullous pemphigoid: IV. Chemotactic activity in blister fluid
NL8320427A (nl) Proef op autoimmune rheumatoide arthritis.
Glueck et al. Abnormal calcium binding associated with hyperglobulinemia, clotting defects, and osteoporosis: a study of this relationship
Avvisati et al. Evaluation of a new chromogenic assay for factor VII and its application in patients on oral anticoagulant treatment
Ratnoff et al. Wasp sting anaphylaxis
CA1215923A (en) Reagent for determination of blood coagulation factor xiii
CA2490184A1 (en) Control plasma for thrombin activity tests
Stormorken et al. Diagnosis of heterozygotes in Glanzmann’s thrombasthenia
Lasser et al. The plasma contact system in atopic asthma
Thompson Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients
Forastiero et al. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant
Jacobsen et al. Do antiphospholipid antibodies interfere with tissue factor pathway inhibitor?
Thomas et al. Simplified immunoradiometric assay for factor VIII coagulant antigen
Entman et al. Altered ferrokinetics in toxemia of pregnancy: a possible indicator of decreased red cell survival
Weiss et al. Functions of the Blood